Breaking News Bar

Business News and Information

Viela Bio strikes deal to get rare disease drug to global market

The agreement comes just days after the Maryland company’s initial public offering.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
bottom clear